BRAY F , LAVERSANNE M , SUNG H , et al . Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA Cancer J Clin , 2024 , 74 ( 3 ): 229 - 263 .

GIAQUINTO A N , SUNG H , MILLER K D , et al . Breast cancer statistics, 2022 [J ] . CA A Cancer J Clin , 2022 , 72 ( 6 ): 524 - 541 .

AEBI S , GELBER S , ANDERSON S J , et al . Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial [J ] . Lancet Oncol , 2014 , 15 ( 2 ): 156 - 163 . DOI: 10.1016/S1470-2045(13)70589-8 http://doi.org/10.1016/S1470-2045(13)70589-8

KARLSSON P , COLE B F , CHUA B H , et al . Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report [J ] . Ann Oncol , 2012 , 23 ( 11 ): 2852 - 2858 . DOI: S0923-7534(19)37514-3 http://doi.org/S0923-7534(19)37514-3

FISHER B , MONTAGUE E , REDMOND C , et al . Findings from NSABP Protocol No. B-04-comparison of radical mastectomy with alternative treatments for primary breast cancer. I. Radiation compliance and its relation to treatment outcome [J ] . Cancer , 1980 , 46 ( 1 ): 1 - 13 .

CORSO G , MAGNONI F , MONTAGNA G , et al . Long-term outcome and axillary recurrence in elderly women (≥70 years) with breast cancer: 10-years follow-up from a matched cohort study [J ] . Eur J Surg Oncol , 2021 , 47 ( 7 ): 1593 - 1600 . DOI: 10.1016/j.ejso.2021.02.027 http://doi.org/10.1016/j.ejso.2021.02.027

BROMHAM N , SCHMIDT-HANSEN M , ASTIN M , et al . Axillary treatment for operable primary breast cancer [J ] . Cochrane Database Syst Rev , 2017 , 1 ( 1 ): CD004561.

BILIMORIA K Y , BENTREM D J , HANSEN N M , et al . Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer [J ] . J Clin Oncol , 2009 , 27 ( 18 ): 2946 - 2953 . DOI: 10.1200/JCO.2008.19.5750 http://doi.org/10.1200/JCO.2008.19.5750

TVEDSKOV T F , JENSEN M B , EJLERTSEN B , et al . Prognostic significance of axillary dissection in breast cancer patients with micrometastases or isolated tumor cells in sentinel nodes: a nationwide study [J ] . Breast Cancer Res Treat , 2015 , 153 ( 3 ): 599 - 606 .

HOUVENAEGHEL G , BOHER J M , REYAL F , et al . Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes [J ] . Eur J Cancer , 2016 , 67 : 106 - 118 . DOI: S0959-8049(16)32364-4 http://doi.org/S0959-8049(16)32364-4

GIULIANO A E , BALLMAN K V , MCCALL L , et al . Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial [J ] . JAMA , 2017 , 318 ( 10 ): 918 - 926 .

DE BONIFACE J , TVEDSKOV T F , RYDÉN L , et al . Omitting axillary dissection in breast cancer with sentinel-node metastases [J ] . N Engl J Med , 2024 , 390 ( 13 ): 1163 - 1175 .

LIM S Z , KUSUMAWIDJAJA G , MOHD ISHAK H M , et al . Outcomes of stage Ⅰ and Ⅱ breast cancer with nodal micrometastases treated with mastectomy without axillary therapy [J ] . Breast Cancer Res Treat , 2021 , 189 ( 3 ): 837 - 843 .

VERONESI U , PAGANELLI G , VIALE G , et al . A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer [J ] . N Engl J Med , 2003 , 349 ( 6 ): 546 - 553 .

VAN DER PLOEG I C , NIEWEG O E , VAN RIJK M C , et al . Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature [J ] . Eur J Surg Oncol , 2008 , 34 ( 12 ): 1277 - 1284 . DOI: 10.1016/j.ejso.2008.01.034 http://doi.org/10.1016/j.ejso.2008.01.034

VAN WELY B J , VAN DEN WILDENBERG F J H , GOBARDHAN P , et al . Axillary recurrences after sentinel lymph node biopsy: a multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients [J ] . Eur J Surg Oncol , 2012 , 38 ( 10 ): 925 - 931 .

VERONESI U , PAGANELLI G , VIALE G , et al . Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study [J ] . Lancet Oncol , 2006 , 7 ( 12 ): 983 - 990 . DOI: 10.1016/S1470-2045(06)70947-0 http://doi.org/10.1016/S1470-2045(06)70947-0

KRAG D N , ANDERSON S J , JULIAN T B , et al . Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial [J ] . Lancet Oncol , 2010 , 11 ( 10 ): 927 - 933 . DOI: 10.1016/S1470-2045(10)70207-2 http://doi.org/10.1016/S1470-2045(10)70207-2

OGIYA A , KIMURA K , NAKASHIMA E , et al . Long-term prognoses and outcomes of axillary lymph node recurrence in 2 578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital [J ] . Breast Cancer , 2016 , 23 ( 2 ): 318 - 322 .

PEPELS M J , VESTJENS J H M J , DE BOER M , et al . Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review [J ] . Breast Cancer Res Treat , 2011 , 125 ( 2 ): 301 - 313 .

MATSEN C , VILLEGAS K , EATON A , et al . Late axillary recurrence after negative sentinel lymph node biopsy is uncommon [J ] . Ann Surg Oncol , 2016 , 23 ( 8 ): 2456 - 2461 . DOI: 10.1245/s10434-016-5151-1 http://doi.org/10.1245/s10434-016-5151-1

MARTELLI G , BARRETTA F , MICELI R , et al . Sentinel node biopsy alone or with axillary dissection in breast cancer patients after primary chemotherapy: long-term results of a prospective interventional study [J ] . Ann Surg , 2022 , 276 ( 5 ): e544-e552.

CRUZ H S S , VERDIAL F C , SHANNO J N , et al . Axillary recurrence in sentinel lymph node negative mastectomy patients at 16 years median follow up: natural history in the absence of radiation [J ] . Clin Breast Cancer , 2025 , 25 ( 1 ): e63-e70.

GENTILINI O D , BOTTERI E , SANGALLI C , et al . Sentinel lymph node biopsy vs no axillary surgery in patients with s mall breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial [J ] . JAMA Oncol , 2023 , 9 ( 11 ): 1557 - 1564 .

VAN ROOZENDAAL L M , VANE M G , VAN DALEN T , et al . Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08) [J ] . BMC Cancer , 2017 , 17 ( 1 ): 459 . DOI: 10.1186/s12885-017-3443-x http://doi.org/10.1186/s12885-017-3443-x

NADEEM R M . The feasibility of SNIPE trial; sentinel lymph node biopsy vs no-SLNB in patient s with early breast cancer [J ] . Cancer Res , 2013 , 73 ( 24_Supplement ): P1-1-26-P1-01-26.

LYMAN G H , TEMIN S , EDGE S B , et al . Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update [J ] . J Clin Oncol , 2014 , 32 ( 13 ): 1365 - 1383 . DOI: 10.1200/JCO.2013.54.1177 http://doi.org/10.1200/JCO.2013.54.1177

GIULIANO A E , MCCALL L , BEITSCH P , et al . Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial [J ] . Ann Surg , 2010 , 252 ( 3 ): 426-432; discussion 432-433.

GIULIANO A E , BALLMAN K , MCCALL L , et al . Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (alliance) ACOSOG Z0011 randomized trial [J ] . Ann Surg , 2016 , 264 ( 3 ): 413 - 420 . DOI: 10.1097/SLA.0000000000001863 http://doi.org/10.1097/SLA.0000000000001863

FAN Y J , LI J C , ZHU D M , et al . Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis [J ] . BMC Surg , 2023 , 23 ( 1 ): 209 .

LI C Z , ZHANG P , LV J , et al . Axillary management in patients with clinical node-negative early breast cancer and positive sentinel lymph node: a systematic review and meta-analysis [J ] . Front Oncol , 2024 , 13 : 1320867 .

BARTELS S A L , DONKER M , PONCET C , et al . Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS trial [J ] . J Clin Oncol , 2023 , 41 ( 12 ): 2159 - 2165 .

GAO W Q , LU S S , ZENG Y F , et al . Axilla lymph node dissection can be safely omitted in patients with 1-2 positive sentinel nodes receiving mastectomy: a large multi-institutional study and a systemic meta-analysis [J ] . Breast Cancer Res Treat , 2022 , 196 ( 1 ): 129 - 141 .

ZAVERI S , EVERIDGE S , FITZSULLIVAN E , et al . Extremely low incidence of local-regional recurrences observed among T1-2N1 (1 or 2 positive SLNs) breast cancer patients receiving upfront mastectomy without completion axillary node dissection [J ] . Ann Surg Oncol , 2023 , 30 ( 12 ): 7015 - 7025 .

GALIMBERTI V , COLE B F , ZURRIDA S , et al . Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial [J ] . Lancet Oncol , 2013 , 14 ( 4 ): 297 - 305 . DOI: 10.1016/S1470-2045(13)70035-4 http://doi.org/10.1016/S1470-2045(13)70035-4

SNOW R , REYNA C , JOHNS C , et al . Outcomes with and without axillary node dissection for node-positive lumpectomy and mastectomy patients [J ] . Am J Surg , 2015 , 210 ( 4 ): 685 - 693 . DOI: 10.1016/j.amjsurg.2015.05.004 http://doi.org/10.1016/j.amjsurg.2015.05.004

FITZSULLIVAN E , BASSETT R L , KUERER H M , et al . Outcomes of sentinel lymph node-positive breast cancer patients treated with mastectomy without axillary therapy [J ] . Ann Surg Oncol , 2017 , 24 ( 3 ): 652 - 659 . DOI: 10.1245/s10434-016-5605-5 http://doi.org/10.1245/s10434-016-5605-5

JOO J H , KIM S S , SON B H , et al . Axillary lymph node dissection does not improve post-mastectomy overall or disease-free survival among breast cancer patients with 1-3 positive nodes [J ] . Cancer Res Treat , 2019 , 51 ( 3 ): 1011 - 1021 . DOI: 10.4143/crt.2018.438 http://doi.org/10.4143/crt.2018.438

TINTERRI C , CANAVESE G , GATZEMEIER W , et al . Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment [J ] . Br J Surg , 2023 , 110 ( 9 ): 1143 - 1152 .

WEBER W P , HANSON S E , WONG D E , et al . Personalizing locoregional therapy in patients with breast cancer in 2024: tailoring axillary surgery, escalating lymphatic surgery, and implementing evidence-based hypofractionated radiotherapy [J ] . Am Soc Clin Oncol Educ Book , 2024 , 44 ( 3 ): e438776 .

CAUDLE A S , YANG W T , KRISHNAMURTHY S , et al . Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection [J ] . J Clin Oncol , 2016 , 34 ( 10 ): 1072 - 1078 . DOI: 10.1200/JCO.2015.64.0094 http://doi.org/10.1200/JCO.2015.64.0094

PILTIN M A , HOSKIN T L , DAY C N , et al . Oncologic outcomes of sentinel lymph node surgery after neoadjuvant chemotherapy for node-positive breast cancer [J ] . Ann Surg Oncol , 2020 , 27 ( 12 ): 4795 - 4801 .

WONG S M , BASIK M , FLORIANOVA L , et al . Oncologic safety of sentinel lymph node biopsy alone after neoadjuvant chemotherapy for breast cancer [J ] . Ann Surg Oncol , 2021 , 28 ( 5 ): 2621 - 2629 . DOI: 10.1245/s10434-020-09211-0 http://doi.org/10.1245/s10434-020-09211-0

KUEMMEL S , HEIL J , BRUZAS S , et al . Safety of targeted axillary dissection after neoadjuvant therapy in patients with node-positive breast cancer [J ] . JAMA Surg , 2023 , 158 ( 8 ): 807 - 815 . DOI: 10.1001/jamasurg.2023.1772 http://doi.org/10.1001/jamasurg.2023.1772

MONTAGNA G , MRDUTT M M , SUN S X , et al . Omission of axillary dissection following nodal downstaging with neoadjuvant chemotherapy [J ] . JAMA Oncol , 2024 , 10 ( 6 ): 793 - 798 . DOI: 10.1001/jamaoncol.2024.0578 http://doi.org/10.1001/jamaoncol.2024.0578

KOMENAKA I K , BAUER V P , SCHNABEL F R , et al . Interpectoral nodes as the initial site of recurrence in breast cancer [J ] . Arch Surg , 2004 , 139 ( 2 ): 175 - 178 .

HANSEN S M , HOYER U . A case of locoregional recurrence of breast cancer in the interpectoral lymph nodes: an unusual location [J ] . Ann Breast Surg , 2019 , 3 : 6 .

JATOI I , HILSENBECK S G , CLARK G M , et al . Significance of axillary lymph node metastasis in primary breast cancer [J ] . J Clin Oncol , 1999 , 17 ( 8 ): 2334 - 2340 .

TAGHIAN A , JEONG J H , MAMOUNAS E , et al . Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials [J ] . J Clin Oncol , 2004 , 22 ( 21 ): 4247 - 4254 . DOI: 10.1200/JCO.2004.01.042 http://doi.org/10.1200/JCO.2004.01.042

GARCÍA FERNÁNDEZ A , CHABRERA C , GARCÍA FONT M , et al . Positive versus negative sentinel nodes in early breast cancer patients: axillary or loco-regional relapse and survival. A study spanning 2000-2012 [J ] . Breast , 2013 , 22 ( 5 ): 902 - 907 . DOI: 10.1016/j.breast.2013.04.015 http://doi.org/10.1016/j.breast.2013.04.015

CHEN X X , YU X L , CHEN J Y , et al . Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: patterns of failure and prognostic factors [J ] . Cancer , 2013 , 119 ( 13 ): 2366 - 2374 . DOI: 10.1002/cncr.28085 http://doi.org/10.1002/cncr.28085

WAPNIR I L , ANDERSON S J , MAMOUNAS E P , et al . Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials [J ] . J Clin Oncol , 2006 , 24 ( 13 ): 2028 - 2037 . DOI: 10.1200/JCO.2005.04.3273 http://doi.org/10.1200/JCO.2005.04.3273

GALIMBERTI V , MANIKA A , MAISONNEUVE P , et al . Long-term follow-up of 5 262 breast cancer patients with negative sentinel node and no axillary dissection confirms low rate of axillary disease [J ] . Eur J Surg Oncol , 2014 , 40 ( 10 ): 1203 - 1208 .

ANDRING L M , DIAO K , SUN S , et al . Locoregional management and prognostic factors in breast cancer with ipsilateral internal mammary and axillary lymph node involvement [J ] . Int J Radiat Oncol Biol Phys , 2022 , 113 ( 3 ): 552 - 560 .

STROM E A , WOODWARD W A , KATZ A , et al . Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy [J ] . Int J Radiat Oncol Biol Phys , 2005 , 63 ( 5 ): 1508 - 1513 .

GRUBER G , COLE B F , CASTIGLIONE-GERTSCH M , et al . Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer [J ] . Ann Oncol , 2008 , 19 ( 8 ): 1393 - 1401 . DOI: S0923-7534(19)40248-2 http://doi.org/S0923-7534(19)40248-2

NAOUM G E , OLADERU O , ABABNEH H , et al . Pathologic exploration of the axillary soft tissue microenvironment and its impact on axillary management and breast cancer outcomes [J ] . J Clin Oncol , 2024 , 42 ( 2 ): 157 - 169 .

GENTILINI O , BOTTERI E , LEONARDI M C , et al . Ipsilateral axillary recurrence after breast conservative surgery: the protective effect of whole breast radiotherapy [J ] . Radiother Oncol , 2017 , 122 ( 1 ): 37 - 44 . DOI: S0167-8140(16)34462-0 http://doi.org/S0167-8140(16)34462-0

MAGNONI F , CORSO G , MAISONNEUVE P , et al . Comparison of long-term outcome between clinically high risk lobular versus ductal breast cancer: a propensity score matched study [J ] . EClinicalMedicine , 2024 , 71 : 102552 .

SEKINE C , NAKANO S , MIBU A , et al . Breast cancer hormone receptor negativity, triple-negative type, mastectomy and not receiving adjuvant radiotherapy were associated with axillary recurrence after sentinel lymph node biopsy [J ] . Asian J Surg , 2020 , 43 ( 1 ): 148 - 153 . DOI: S1015-9584(18)30808-X http://doi.org/S1015-9584(18)30808-X

CAMPBELL I , WETZIG N , UNG O , et al . 10-year axillary recurrence in the RACS SNAC1 randomised trial of sentinel lymph node-based management versus routine axillary lymph node dissection [J ] . Breast , 2023 , 70 : 70 - 75 . DOI: 10.1016/j.breast.2023.06.009 http://doi.org/10.1016/j.breast.2023.06.009

DE BONIFACE J , FRISELL J , BERGKVIST L , et al . Breast-conserving surgery followed by whole-breast irradiation offers survival benefits over mastectomy without irradiation [J ] . Br J Surg , 2018 , 105 ( 12 ): 1607 - 1614 . DOI: 10.1002/bjs.10889 http://doi.org/10.1002/bjs.10889

VAN WELY B J , TEERENSTRA S , SCHINAGL D X , et al . Systematic review of the effect of external beam radiation therapy to the breast on axillary recurrence after negative sentinel lymph node biopsy [J ] . Br J Surg , 2011 , 98 ( 3 ): 326 - 333 . DOI: 10.1002/bjs.7360 http://doi.org/10.1002/bjs.7360

CHEUN J H , KIM H K , MOON H G , et al . Locoregional recurrence patterns in patients with different molecular subtypes of breast cancer [J ] . JAMA Surg , 2023 , 158 ( 8 ): 841 - 852 .

SÁVOLT Á , PÉLEY G , POLGÁR C , et al . Eight-year follow up result of the OTOASOR trial: the optimal treatment of the axilla-surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase Ⅲ, non-inferiority trial [J ] . Eur J Surg Oncol EJSO , 2017 , 43 ( 4 ): 672 - 679 .

VERONESI U , ORECCHIA R , ZURRIDA S , et al . Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy [J ] . Ann Oncol , 2005 , 16 ( 3 ): 383 - 388 . DOI: 10.1093/annonc/mdi089 http://doi.org/10.1093/annonc/mdi089

LEE S B , KIM H , KIM J , et al . Prognosis according to clinical and pathologic lymph node status in breast cancer patients who underwent sentinel lymph node biopsy alone after neoadjuvant therapy [J ] . PLoS One , 2021 , 16 ( 5 ): e0251597 .

ZHAO X R , TANG Y , WANG S L , et al . Locoregional recurrence patterns in women with breast cancer who have not undergone post-mastectomy radiotherapy [J ] . Radiat Oncol , 2020 , 15 ( 1 ): 212 . DOI: 10.1186/s13014-020-01637-w http://doi.org/10.1186/s13014-020-01637-w

ABI-RAAD R , BOUTRUS R , WANG R , et al . Patterns and risk factors of locoregional recurrence in T1-T2 node negative breast cancer patients treated with mastectomy: implications for postmastectomy radiotherapy [J ] . Int J Radiat Oncol Biol Phys , 2011 , 81 ( 3 ): e151 - 7 .

KARLSSON P , COLE B F , PRICE K N , et al . The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer [J ] . J Clin Oncol , 2007 , 25 ( 15 ): 2019 - 2026 . DOI: 10.1200/JCO.2006.09.8152 http://doi.org/10.1200/JCO.2006.09.8152

VANE M L G , MOOSSDORFF M , VAN MAAREN M C , et al . Conditional regional recurrence risk: the effect of event-free years in different subtypes of breast cancer [J ] . Eur J Surg Oncol , 2021 , 47 ( 6 ): 1292 - 1298 . DOI: 10.1016/j.ejso.2020.11.122 http://doi.org/10.1016/j.ejso.2020.11.122

WU H L , LU Y J , LI J W , et al . Prior local or systemic treatment: a predictive model could guide clinical decision-making for locoregional recurrent breast cancer [J ] . Front Oncol , 2022 , 11 : 791995 .

HARRIS E E R , HWANG W T , SEYEDNEJAD F , et al . Prognosis after regional lymph node recurrence in patients with stage Ⅰ-Ⅱ breast carcinoma treated with breast conservation therapy [J ] . Cancer , 2003 , 98 ( 10 ): 2144 - 2151 .

SEKI H , OGIYA A , NAGURA N , et al . Prognosis of isolated locoregional recurrence after early breast cancer with immediate breast reconstruction surgery: a retrospective multi-institutional study [J ] . Breast Cancer , 2024 , 31 ( 5 ): 935 - 944 .

DE BOER R , HILLEN H F , ROUMEN R M , et al . Detection, treatment and outcome of axillary recurrence after axillary clearance for invasive breast cancer [J ] . Br J Surg , 2001 , 88 ( 1 ): 118 - 122 .

VOOGD A C , CRANENBROEK S , DE BOER R , et al . Long-term prognosis of patients with axillary recurrence after axillary dissection for invasive breast cancer [J ] . Eur J Surg Oncol EJSO , 2005 , 31 ( 5 ): 485 - 489 .

FREDRIKSSON I , LILJEGREN G , ARNESSON L G , et al . Consequences of axillary recurrence after conservative breast surgery [J ] . Br J Surg , 2002 , 89 ( 7 ): 902 - 908 .

BULTE J P , VAN WELY B J , KASPER S , et al . Long-term follow-up of axillary recurrences after negative sentinel lymph node biopsy: effect on prognosis and survival [J ] . Breast Cancer Res Treat , 2013 , 140 ( 1 ): 143 - 149 .

KUO S H , HUANG C S , KUO W H , et al . Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence [J ] . Int J Radiat Oncol Biol Phys , 2008 , 72 ( 5 ): 1456 - 1464 .

LEE Y J , PARK H , KANG C M , et al . Risk stratification system for groups with a low, intermediate, and high risk of subsequent distant metastasis and death following isolated locoregional recurrence of breast cancer [J ] . Breast Cancer Res Treat , 2020 , 179 ( 2 ): 315 - 324 .

SKINNER H D , STROM E A , MOTWANI S B , et al . Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy [J ] . Radiat Oncol , 2013 , 8 : 13 . DOI: 10.1186/1748-717X-8-13 http://doi.org/10.1186/1748-717X-8-13

PEDERSEN R N , MELLEMKJÆR L , EJLERTSEN B , et al . Mortality after late breast cancer recurrence in Denmark [J ] . J Clin Oncol , 2022 , 40 ( 13 ): 1450 - 1463 . DOI: 10.1200/JCO.21.02062 http://doi.org/10.1200/JCO.21.02062

MORGAN J L , CHENG V , BARRY P A , et al . The MARECA (national study of management of breast cancer locoregional recurrence and oncological outcomes) study: national practice questionnaire of United Kingdom multi-disciplinary decision making [J ] . Eur J Surg Oncol , 2022 , 48 ( 7 ): 1510 - 1519 . DOI: 10.1016/j.ejso.2022.03.017 http://doi.org/10.1016/j.ejso.2022.03.017

NEWMAN L A , HUNT K K , BUCHHOLZ T , et al . Presentation, management and outcome of axillary recurrence from breast cancer [J ] . Am J Surg , 2000 , 180 ( 4 ): 252 - 256 .

KONKIN D E , TYLDESLEY S , KENNECKE H , et al . Management and outcomes of isolated axillary node recurrence in breast cancer [J ] . Arch Surg , 2006 , 141 ( 9 ): 867-872; discussion 872 - 874 .

National Comprehensive Cancer Network . Clinical practice guidelines in oncology, 2024 [EB/OL ] . Breast cancer (version 4.2024) . ( 2024 - 07 - 03 ) [ 2024 - 8 - 24 ] . https://www.nccn.org/ https://www.nccn.org/ https://www.nccn.org/ .

郝晓鹏 , 陈玉辉 , 王建东 . 中国乳腺癌术后局部和区域淋巴结复发外科诊治指南(2024版) [J ] . 中国实用外科杂志 , 2024 , 44 ( 2 ): 134 - 138 .

HAO X P , CHEN Y H , WANG J D . Chinese guidelines for surgical diagnosis and treatment of local and regional lymph node recurrence after breast cancer surgery(2024 edition) [J ] . Chin J Pract Surg , 2024 , 44 ( 2 ): 134 - 138 .

WAPNIR I L , PRICE K N , ANDERSON S J , et al . Efficacy of chemotherapy for ER-negative and ER-positive isolated locoregional recurrence of breast cancer: final analysis of the CALOR trial [J ] . J Clin Oncol , 2018 , 36 ( 11 ): 1073 - 1079 . DOI: 10.1200/JCO.2017.76.5719 http://doi.org/10.1200/JCO.2017.76.5719

ZHAO S , CHEN D P , FU T , et al . Single-cell morphological and topological atlas reveals the ecosystem diversity of human breast cancer [J ] . Nat Commun , 2023 , 14 ( 1 ): 6796 . DOI: 10.1038/s41467-023-42504-y http://doi.org/10.1038/s41467-023-42504-y

WANG K L , KUMAR T , WANG J K , et al . Archival single-cell genomics reveals persistent subclones during DCIS progression [J ] . Cell , 2023 , 186 ( 18 ): 3968 - 3982 .e15. DOI: 10.1016/j.cell.2023.07.024 http://doi.org/10.1016/j.cell.2023.07.024

COOMBES R C , PAGE K R , SALARI R , et al . Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence [J ] . Clin Cancer Res , 2019 , 25 ( 14 ): 4255 - 4263 . DOI: 10.1158/1078-0432.CCR-18-3663 http://doi.org/10.1158/1078-0432.CCR-18-3663

OLSSON E , WINTER C , GEORGE A , et al . Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease [J ] . EMBO Mol Med , 2015 , 7 ( 8 ): 1034 - 1047 . DOI: 10.15252/emmm.201404913 http://doi.org/10.15252/emmm.201404913

BIDARD F C , HARDY-BESSARD A C , DALENC F , et al . Switch to fulvestrant and palbociclib versus no switch in advanced breast canc er with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial [J ] . Lancet Oncol , 2022 , 23 ( 11 ): 1367 - 1377 .

PAPAKONSTANTINOU A , GONZALEZ N S , PIMENTEL I , et al . Prognostic value of ctDNA detection in patients with early breast cancer undergoing neoadjuvant therapy: a systematic review and meta-analysis [J ] . Cancer Treat Rev , 2022 , 104 : 102362 .